Tag: CRSP

Science

Why Acquire Shares Of CRISPR Therapeutics AG (CRSP)?

CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.75 and has seen 0.95 million shares traded in the recent trading session. The company, currently

Science

CRISPR Therapeutics AG (NASDAQ:CRSP) Dropped -15.40% In One Month

CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.79 and has seen 1.21 million shares traded in the last trading session. The company, currently

Company

CRSP’s -9.27% Loss This Week Has Revealed Something We Didn’t Know Before

During the last session, CRISPR Therapeutics AG (NASDAQ:CRSP)’s traded shares were 1.73 million, with the beta value of the company hitting 1.78. At the end

US Market Overview

What Is Happening With CRISPR Therapeutics AG (CRSP)? Sentiment Analysis

CRISPR Therapeutics AG (NASDAQ: CRSP) expects to submit an application for gene therapy approval by the end of the year. This medicine already earned good

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: CRSP

Why Acquire Shares Of CRISPR Therapeutics AG (CRSP)?

CRISPR Therapeutics AG (NASDAQ:CRSP) Dropped -15.40% In One Month

CRSP’s -9.27% Loss This Week Has Revealed Something We Didn’t Know Before

What Is Happening With CRISPR Therapeutics AG (CRSP)? Sentiment Analysis

Categories

Quick Links